CD274 and neoplasm: Fakri et al. reported 34.4% PD-L1 expression in ICs in non-small-cell lung cancer [49], while Fu et al. found expression rates of 58.1% in cervical cancer tumor cells, 33.8% in endometrial cancer tumor cells, and 37.5% in ovarian cancer tumor cells [50].